In:
Journal of Translational Medicine, Springer Science and Business Media LLC, Vol. 12, No. 1 ( 2014-12)
Kurzfassung:
Tumor Associated Antigens are characterized by spontaneous immune response in cancer patients as a consequence of overexpression and epitope-presentation on MHC class I/II machinery. Matrix Metalloprotease 11 (MMP11) expression has been associated with poor prognosis for several cancer types, including breast and prostate cancer. Methods MMP11 expression was determined by immunoistochemistry in breast and prostate cancer samples. Circulating MMP11 protein as well as the spontaneous immune responses against MMP11 were analyzed in a set of breast and prostate cancer patients. Results In plasma samples MMP11 protein was present in 5/13 breast cancer patients and in 1/12 prostate cancer patients. An antibody response was observed in 7/13 breast cancer patients and in 3/12 prostate cancer patients. Conclusions These findings further suggest MMP11 as a promising biomarker for these tumor types and a suitable target for cancer immunotherapy strategies.
Materialart:
Online-Ressource
ISSN:
1479-5876
DOI:
10.1186/1479-5876-12-54
Sprache:
Englisch
Verlag:
Springer Science and Business Media LLC
Publikationsdatum:
2014
ZDB Id:
2118570-0
